A detailed history of Bowen Hanes & CO Inc transactions in Boston Scientific Corp stock. As of the latest transaction made, Bowen Hanes & CO Inc holds 41,825 shares of BSX stock, worth $4.3 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
41,825
Previous 414,280 89.9%
Holding current value
$4.3 Million
Previous $44.5 Million 90.82%
% of portfolio
0.11%
Previous 1.15%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 10, 2025

SELL
$97.03 - $108.14 $36.1 Million - $40.3 Million
-372,455 Reduced 89.9%
41,825 $4.08 Million
Q2 2025

Aug 12, 2025

BUY
$89.7 - $107.41 $737,334 - $882,910
8,220 Added 2.02%
414,280 $44.5 Million
Q1 2025

May 14, 2025

BUY
$89.38 - $106.18 $4.38 Million - $5.2 Million
48,995 Added 13.72%
406,060 $41 Million
Q4 2024

Feb 10, 2025

BUY
$83.62 - $91.5 $29.9 Million - $32.7 Million
357,065 New
357,065 $31.9 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $147B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Bowen Hanes & CO Inc Portfolio

Follow Bowen Hanes & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bowen Hanes & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bowen Hanes & CO Inc with notifications on news.